Sabra Health Care REIT Inc.’s filing revealed that its Executive VP, CFO & Secretary Costa Michael Lourenco acquired Company’s shares for reported $24591.0 on Sep 01. In the deal valued at $12.63 per share,1,947 shares were bought. As a result of this transaction, Costa Michael Lourenco now holds 183,218 shares worth roughly $ 2.44 million.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
BofA Securities upgraded its Sabra Health Care REIT Inc. [SBRA] rating to a Neutral from a an Underperform in a research note published on Monday, August 11, 2023; the price target was increased to $14 from $11. PT values the company’s stock at a premium of 4.86 to its Monday closing price.
Price Performance Review of SBRA
On Monday, Sabra Health Care REIT Inc. [NASDAQ:SBRA] saw its stock fall -0.45% to $13.32. On the same session, the stock had its day’s lowest price of $13.305, but rose to a high of $13.455. Over the last five days, the stock has gained 0.91%. Sabra Health Care REIT Inc. shares have risen nearly 7.16% since the year began. Nevertheless, the stocks have fallen -1.34% over the past one year. While a 52-week high of $14.23 was reached on 02/02/23, a 52-week low of $10.08 was recorded on 03/24/23. SMA at 50 days reached $12.68, while 200 days put it at $12.16. A total of 1.97 million shares were traded, compared to the trading of 2.97 million shares in the previous session.
Levels Of Support And Resistance For SBRA Stock
The 24-hour chart illustrates a support level at 13.27, which if violated will result in even more drops to 13.21. On the upside, there is a resistance level at 13.41. A further resistance level may holdings at 13.51. The Relative Strength Index (RSI) on the 14-day chart is 64.56, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.42, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 15.28%. Stochastics %K at 87.96% indicates the stock is a selling.
How much short interest is there in Sabra Health Care REIT Inc.?
A steep rise in short interest was recorded in Sabra Health Care REIT Inc. stocks on Aug 30, 2023, growing by 2.03 million shares to a total of 13.65 million shares. Yahoo Finance data shows the prior-month short interest on Jul 30, 2023 was 11.62 million shares. There was a rise of 14.87%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 8.48% of the overall stock float, the days-to-cover ratio (short ratio) rose to 6.61.
Sabra Health Care REIT Inc. [SBRA] – Who Are The Largest Shareholders?
In filings from The Vanguard Group, Inc., it is revealed that the company now owns 33,737,965 shares, or roughly 14.59% of the outstanding SBRA shares. In other words, the investor’s shares have fallen by -1,208,786 from its previous 13-F filing of 34946751.0. Additionally, BlackRock Fund Advisors increased 0.47% of its stake after which the total value it holdings stand at $353,552,432, while Principal Global Investors LLC added 32.21% of its stake to hold $259.24 million in the firm. At present, Geode Capital Management LLC is holding 5,394,150 shares valued at $67.59 million. LSV Asset Management owned 4,241,249 shares of the company at the time of its most recent 13F filing, worth $53.14 million.
According to FactSet, Sabra Health Care REIT Inc.’s share price will average $13.29 in the next year, based on opinions of analysts polled by the firm. This is down nearly -2.84 percent from its previous closing price of $13.38. Analysts expect Sabra Health Care REIT Inc. stock to reach the higher price of $15.00, while the lowest price estimate is $11.00. However, 15 analysts have rated SBRA stock as a Hold in their predictions for 2023.